BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$7.52 USD
-0.33 (-4.20%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $7.51 -0.01 (-0.13%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth F Momentum F VGM
Brokerage Reports
0 items in cart
BioCryst Pharmaceuticals, Inc. [BCRX]
Reports for Purchase
Showing records 161 - 176 ( 176 total )
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
Gout Program Moves Into Advanced Phase 2 Development
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
3Q10 - NEW WAVE OF BCX-4208 STUDIES PUT GOUT PROGRAM IN HIGH GEAR
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
Expanded Label for Pediatric Use of Peramivir in Japan Provides Upside to Shionogi Royalties
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology / Biopharmaceuticals -Preview of Gout Abstracts at the Upcoming ACR
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
BCX4208 SHOWS SYNERGY WITH ALLOPURINOL IN GOUT ? UPGRADING TO OUTPERFORM
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
Partner Green Cross Receives Marketing Approval for Peramivir in South Korea
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
2Q10 - BCX4208 SHOWS DOSE RESPONSE IN GOUT - FORODESINE DATA IN 2H10
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: BioCryst Pharmaceuticals, Inc.
Industry: Medical - Drugs
1Q10 UPDATE - BCX4208 SHOWS EFFICACY IN GOUT FORODESINE DATA IN 2H10
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R